Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors
Open Access
- 26 June 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 13 (1), 311-10
- https://doi.org/10.1186/1471-2407-13-311
Abstract
Background High mobility group protein box 1 (HMGB1) is a DNA binding protein located in nucleus. It is released into extracellular fluid where it acts as a novel proinflammatory cytokine which interacts with Toll like receptor 4 (TLR4) to activate nuclear factor-κB (NF-κB). This sequence of events is involved in tumor growth and progression. However, the effects of HMGB1, TLR4 and NF-κB on epidermal tumors remain unclear. Methods Human epidermal tumor specimens were obtained from 96 patients. Immunohistochemistry was used to detect expression of HMGB1, TLR4 and NF-κB p65 in human epidermal tumor and normal skin specimens. Western blot analysis was used to detect the expression of NF-κB p65 in epithelial cell nuclei in human epidermal tumor and normal tissues. Results Immunohistochemistry and western blot analysis indicated a progressive but statistically significant increase in p65 expression in epithelial nuclei in benign seborrheic keratosis (SK), precancerous lesions (PCL), low malignancy basal cell carcinoma (BCC) and high malignancy squamous cell carcinoma (SCC) (P <0.01). The level of extracellular HMGB1 in SK was significantly higher than in normal skin (NS) (P <0.01), and was higher than in SCC but without statistical significance. The level of TLR4 on epithelial membranes of SCC cells was significantly higher than in SK, PCL, BCC and NS (P <0.01). There was a significant positive correlation between p65 expression in the epithelial nuclei and TLR4 expression on the epithelial cell membranes (r = 0.3212, P <0.01). Conclusions These findings indicate that inflammation is intensified in parallel with increasing malignancy. They also indicate that the TLR4 signaling pathway, rather than HMGB1, may be the principal mediator of inflammation in high-grade malignant epidermal tumors. Combined detection of p65 in the epithelial nuclei and TLR4 on the epithelial membranes may assist the accurate diagnosis of malignant epidermal tumors.Keywords
This publication has 40 references indexed in Scilit:
- Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant MesotheliomaCancer Research, 2012
- Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammationMolecular Cancer, 2012
- EditorialInternational Journal of Cancer, 2010
- Persistent Cyclooxygenase-2 Inhibition Downregulates NF-κB, Resulting in Chronic Intestinal Inflammation in the Min/+ Mouse Model of Colon TumorigenesisCancer Research, 2010
- HMGB1 and RAGE in Inflammation and CancerAnnual Review of Immunology, 2010
- Extracellular High Mobility Group Box-1 (HMGB1) Inhibits Enterocyte Migration via Activation of Toll-like Receptor-4 and Increased Cell-Matrix AdhesivenessPublished by Elsevier BV ,2010
- Masquerader: High Mobility Group Box-1 and CancerClinical Cancer Research, 2007
- Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer.2007
- DAMPs, PAMPs and alarmins: all we need to know about dangerJournal of Leukocyte Biology, 2006
- HMGB1 is an endogenous immune adjuvant released by necrotic cellsEMBO Reports, 2004